| NCT ID | NCT02497534 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Friedreich's Ataxia |
| Study Type | OBSERVATIONAL |
| Enrollment | 203 participants |
| Start Date | 2015-09 |
| Primary Completion | 2030-06-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 203 participants in total. It began in 2015-09 with a primary completion date of 2030-06-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this project is to characterize measures of cardiac performance and neuromuscular physiology in FA patients using novel techniques, including echocardiography and magnetic resonance imaging (MRI), metabolic exercise testing, and neurophysiological outcomes.
Eligibility Criteria
Inclusion Criteria: * Genetic diagnosis of Friedreich's ataxia by DNA sequencing, mutational analysis or protein assay OR be a healthy subject with no evidence of a neuromuscular disorder * Between the ages of 6 and 70 (inclusive) * Are able to tolerate metabolic exercise testing * Are stable on cardiac medication regimen for 3 months prior to screening Exclusion Criteria: * Presence of unstable heart disease * Receipt of cardiac transplant * Any concurrent medical condition which, in the opinion of the investigators, would make the subject unsuitable for the study
Contact & Investigator
Manuela Corti, PT, PhD
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT02497534 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 70 Years, studying Friedreich's Ataxia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02497534 currently recruiting?
Yes, NCT02497534 is actively recruiting participants. Contact the research team at mcoker@peds.ufl.edu for enrollment information.
Where is the NCT02497534 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT02497534 clinical trial?
NCT02497534 is sponsored by University of Florida. The principal investigator is Manuela Corti, PT, PhD at University of Florida. The trial plans to enroll 203 participants.